Promomed Group will take part in the International Export Forum "Made in Russia"

Promomed Group of Companies, one of the leaders of the Russian pharmaceutical market, will participate in the International Export Forum "Made in Russia", which will be held in Moscow on October 19-20.

This year, the forum, which is a key international platform for discussing topical issues of export activities and developing practical solutions for developing the competitiveness of Russian companies in the international market, will be held for the fifth time. Representatives of the Promomed group of companies will take part in the business program of the forum, discuss with participants and potential partners ways for cooperation and new developments in priority areas, including oncology, antiviral therapy, neurology, endocrinology and others.

The forum will bring together heads of federal and regional executive authorities, representatives of small, medium and large businesses, as well as expert communities and business associations. The program of the forum will include both the exhibition part, the exposition, and business, round tables and plenary sessions. Special attention at this year's forum will be paid to the regions of Russia, and the export potential of each of the country's regions is planned to be highlighted as widely as possible. The exhibition will be divided into clusters: "Industry", "Ecology", "Smart City", "IT", "Medicine", "Construction", "Agricultural machinery", "Education", "Consumer goods".

As part of the forum's business program, participants will discuss the specifics of high-tech exports, their new geography, export prospects in the field of creative ideas and products, as well as other topics. The forum will also host an awards ceremony for the winners of the All-Russian Exporter of the Year competition, which will highlight companies that have managed to increase exports and successfully enter new markets.

The development of the export direction is one of the priorities for the Promomed Group of companies. Having its own strong production site, the Saransk Biochemist plant, as well as a strong R&D division, which currently has more than 190 new drugs in operation, the group of companies is ready to consider a variety of options for cooperation with friendly countries interested in high-quality Russian-made medicines or technologies. Promomed Group's strategic plans include a large–scale entry into foreign markets. In particular, along with the Middle East and Southeast Asian countries, other areas are also being considered, including African countries.

Participation in the "Made in Russia" forum is a good opportunity for the company to hold talks and discuss future plans with potential partners of the group of companies, to get acquainted with new companies and organizations.